REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmanext Kft. (Hungary)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Pharmanext Kereskedelmi es Szolgaltato Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Pharmanext is a pharmaceutical company specializing in representing OTC medicines, medical devices, and dietary supplements, with a focus on the pharmaceutical and mass market channels. Pharmanext offers national coverage of pharmacy and paed visitation, key account services, and efficient distribution building in pharmacies. The company has expanded its portfolio with brands such as Sterimar, Klosterfrau, and Nasic, and also represents Medis doo.'s OTC portfolio in Hungarian pharmaceutical and retail channels. Pharmanext aims to become a dominant player in the pharmaceutical and mass market channels in Hungary and the CEE region.

Headquarters
Stahly utca 2/A. 3. emelet 3.
Budapest; Budapest; Postal Code: 1085

Contact Details: Purchase the Pharmanext Kft. report to view the information.

Website: http://www.pharmanext.hu

Basic Information
Total Employees:
Purchase the Pharmanext Kft. report to view the information.
Outstanding Shares:
Purchase the Pharmanext Kft. report to view the information.
Financial Auditors:
Purchase the Pharmanext Kft. report to view the information.
Incorporation Date:
August 15, 2019
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Hello Pharma Kereskedelmi es Szolgaltato Kft.
Company Performance
Financial values in the chart are available after Pharmanext Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
34.73%
Total operating revenue
34.59%
Operating profit (EBIT)
67.63%
EBITDA
69.01%
Net Profit (Loss) for the Period
75.25%
Total assets
44.2%
Total equity
139.59%
Operating Profit Margin (ROS)
1.98%
Net Profit Margin
2.04%
Return on Equity (ROE)
-26.82%
Quick Ratio
-0.39%
Cash Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?